Insider · CIK 0001589712
Rachel K. King
Files at: FULC, NVAX, CBIO. On EDGAR ↗
Reported trades — common stock
| Trade | Reported (ET) | Company | Shares | Avg price | Total | Owned after | Δ stake | Flags |
|---|---|---|---|---|---|---|---|---|
| Jun 20, 2026 MForm 4 → | Jun 23, 7:57 pm EDT | NOVAVAX INCNVAX | 18,880 | — | — | 44,070 | — | |
| Sep 8, 2017 GForm 5 → | Feb 14, 2018, 8:52 am EST | GLYCOMIMETICS INCGLYC | 93,204 | — | — | 0 | — | plan? |
| Feb 24, 2015 MForm 4 → | Feb 26, 5:02 pm EST | GLYCOMIMETICS INCGLYC | 50,000 | $1.12 | $56,000 | 167,206 | — | plan? |
Reported trades — derivatives (options, RSUs, warrants)
| Trade | Reported (ET) | Company | Shares | Avg price | Total | Owned after | Δ stake | Flags |
|---|---|---|---|---|---|---|---|---|
| Jun 30, 2026 AForm 4 → | Jul 2, 4:30 pm EDT | Fulcrum Therapeutics, Inc.FULC | 32,000 | — | — | 32,000 | — | |
| Jun 18, 2026 AMForm 4 → | Jun 23, 7:57 pm EDT | NOVAVAX INCNVAX | 54,330 | — | — | 0 | — | |
| Jan 17, 2019 AForm 4 → | Jan 22, 6:22 pm EST | GLYCOMIMETICS INCGLYC | 265,000 | — | — | 265,000 | — | |
| Oct 31, 2018 AForm 4 → | Nov 2, 4:41 pm EDT | NOVAVAX INCNVAX | 160,000 | — | — | 160,000 | — | |
| Jan 10, 2018 AForm 4 → | Jan 12, 4:04 pm EST | GLYCOMIMETICS INCGLYC | 175,000 | — | — | 175,000 | — | |
| Jan 4, 2017 AForm 4 → | Jan 5, 8:50 am EST | GLYCOMIMETICS INCGLYC | 175,000 | — | — | 175,000 | — | |
| Jan 7, 2016 AForm 4 → | Jan 11, 3:18 pm EST | GLYCOMIMETICS INCGLYC | 141,000 | — | — | 141,000 | — | |
| Feb 24, 2015 MForm 4 → | Feb 26, 5:02 pm EST | GLYCOMIMETICS INCGLYC | 50,000 | — | — | 297,580 | — | |
| Jan 8, 2015 AForm 4 → | Jan 12, 4:53 pm EST | GLYCOMIMETICS INCGLYC | 141,000 | — | — | 141,000 | — |